Xtant Medical Holdings Inc (XTNT)
0.5341
-0.01
(-2.22%)
USD |
NYAM |
Nov 01, 16:00
0.5341
0.00 (0.00%)
After-Hours: 20:00
Xtant Medical Holdings Enterprise Value: 102.06M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 102.06M |
| October 31, 2024 | 103.73M |
| October 30, 2024 | 102.33M |
| October 29, 2024 | 105.09M |
| October 28, 2024 | 102.95M |
| October 25, 2024 | 102.46M |
| October 24, 2024 | 102.08M |
| October 23, 2024 | 103.39M |
| October 22, 2024 | 104.29M |
| October 21, 2024 | 104.26M |
| October 18, 2024 | 104.41M |
| October 17, 2024 | 108.96M |
| October 16, 2024 | 107.33M |
| October 15, 2024 | 109.92M |
| October 14, 2024 | 110.61M |
| October 11, 2024 | 111.43M |
| October 10, 2024 | 110.23M |
| October 09, 2024 | 111.19M |
| October 08, 2024 | 117.52M |
| October 07, 2024 | 118.07M |
| October 04, 2024 | 115.31M |
| October 03, 2024 | 115.59M |
| October 02, 2024 | 117.38M |
| October 01, 2024 | 117.38M |
| September 30, 2024 | 121.66M |
| Date | Value |
|---|---|
| September 27, 2024 | 120.84M |
| September 26, 2024 | 121.51M |
| September 25, 2024 | 122.29M |
| September 24, 2024 | 121.58M |
| September 23, 2024 | 130.50M |
| September 20, 2024 | 125.32M |
| September 19, 2024 | 106.75M |
| September 18, 2024 | 104.47M |
| September 17, 2024 | 107.38M |
| September 16, 2024 | 110.54M |
| September 13, 2024 | 107.92M |
| September 12, 2024 | 111.49M |
| September 11, 2024 | 113.24M |
| September 10, 2024 | 107.37M |
| September 09, 2024 | 109.90M |
| September 06, 2024 | 106.35M |
| September 05, 2024 | 105.71M |
| September 04, 2024 | 108.40M |
| September 03, 2024 | 104.40M |
| August 30, 2024 | 130.50M |
| August 29, 2024 | 126.36M |
| August 28, 2024 | 125.74M |
| August 27, 2024 | 126.83M |
| August 26, 2024 | 119.83M |
| August 23, 2024 | 120.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
39.25M
Minimum
Jun 24 2022
389.90M
Maximum
Feb 26 2021
108.35M
Average
94.29M
Median
Sep 21 2021
Enterprise Value Benchmarks
| Plus Therapeutics Inc | 2.817M |
| Perspective Therapeutics Inc | 524.04M |
| Retractable Technologies Inc | -19.02M |
| InfuSystems Holdings Inc | 170.22M |
| Catheter Precision Inc | 2.058M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.861M |
| Revenue (Quarterly) | 29.94M |
| Total Expenses (Quarterly) | 32.89M |
| EPS Diluted (Quarterly) | -0.03 |
| Gross Profit Margin (Quarterly) | 62.06% |
| Profit Margin (Quarterly) | -12.89% |
| Earnings Yield | -3.74% |
| Normalized Earnings Yield | -16.87 |